Spinal injuries and BMX bicycles.

S. Johnson,J. Fairclough

DOI: https://doi.org/10.1136/bmj.294.6582.1259-a

1987-05-16

British Medical Journal

Abstract:2 cas de paraplegie chez des jeunes (13 ans et 17 ans) ayant perdu le controle des engins BMX a grande vitesse

What problem does this paper attempt to address?

An overview of artificial intelligence in diabetic retinopathy and other ocular diseases

Bin Sheng,Xiaosi Chen,Tingyao Li,Tianxing Ma,Yang Yang,Lei Bi,Xinyuan Zhang

DOI: https://doi.org/10.3389/fpubh.2022.971943

IF: 5.2

2022-10-29

Frontiers in Public Health

Abstract:Artificial intelligence (AI), also known as machine intelligence, is a branch of science that empowers machines using human intelligence. AI refers to the technology of rendering human intelligence through computer programs. From healthcare to the precise prevention, diagnosis, and management of diseases, AI is progressing rapidly in various interdisciplinary fields, including ophthalmology. Ophthalmology is at the forefront of AI in medicine because the diagnosis of ocular diseases heavy reliance on imaging. Recently, deep learning-based AI screening and prediction models have been applied to the most common visual impairment and blindness diseases, including glaucoma, cataract, age-related macular degeneration (ARMD), and diabetic retinopathy (DR). The success of AI in medicine is primarily attributed to the development of deep learning algorithms, which are computational models composed of multiple layers of simulated neurons. These models can learn the representations of data at multiple levels of abstraction. The Inception-v3 algorithm and transfer learning concept have been applied in DR and ARMD to reuse fundus image features learned from natural images (non-medical images) to train an AI system with a fraction of the commonly used training data (<1%). The trained AI system achieved performance comparable to that of human experts in classifying ARMD and diabetic macular edema on optical coherence tomography images. In this study, we highlight the fundamental concepts of AI and its application in these four major ocular diseases and further discuss the current challenges, as well as the prospects in ophthalmology.

public, environmental & occupational health
Artificial intelligence and machine learning in ophthalmology: A review

Ojas Srivastava,Matthew Tennant,Parampal Grewal,Uriel Rubin,Mark Seamone

DOI: https://doi.org/10.4103/ijo.ijo_1569_22

2023-01-01

Indian Journal of Ophthalmology

Abstract:Since the introduction of artificial intelligence (AI) in 1956 by John McCarthy, the field has propelled medicine, optimized efficiency, and led to technological breakthroughs in clinical care. As an important frontier in healthcare, AI has implications on every subspecialty within medicine. This review highlights the applications of AI in ophthalmology: a specialty that lends itself well to the integration of computer algorithms due to the high volume of digital imaging, data, and objective metrics such as central retinal thickness. The focus of this review is the use of AI in retina, cornea, anterior segment, and pediatrics.

ophthalmology
Artificial Intelligence in Ophthalmic Surgery: Current Applications and Expectations

Maimaiti Nuliqiman,Mingyu Xu,Yiming Sun,Jing Cao,Pengjie Chen,Qi Gao,Peifang Xu,Juan Ye

DOI: https://doi.org/10.2147/OPTH.S438127

2023-01-01

Clinical Ophthalmology

Abstract:Artificial Intelligence (AI) has found rapidly growing applications in ophthalmology, achieving robust recognition and classification in most kind of ocular diseases. Ophthalmic surgery is one of the most delicate microsurgery, requiring high fineness and stability of surgeons. The massive demand of the AI assist ophthalmic surgery will constitute an important factor in boosting accelerate precision medicine. In clinical practice, it is instrumental to update and review the considerable evidence of the current AI technologies utilized in the investigation of ophthalmic surgery involved in both the progression and innovation of precision medicine. Bibliographic databases including PubMed and Google Scholar were searched using keywords such as "ophthalmic surgery", "surgical selection", "candidate screening", and "robot-assisted surgery" to find articles about AI technology published from 2018 to 2023. In addition to the Editorials and letters to the editor, all types of approaches are considered. In this paper, we will provide an up-to-date review of artificial intelligence in eye surgery, with a specific focus on its application to candidate screening, surgery selection, postoperative prediction, and real-time intraoperative guidance.
Artificial Intelligence (AI) for Early Diagnosis of Retinal Diseases

Uday Pratap Singh Parmar,Pier Luigi Surico,Rohan Bir Singh,Francesco Romano,Carlo Salati,Leopoldo Spadea,Mutali Musa,Caterina Gagliano,Tommaso Mori,Marco Zeppieri

DOI: https://doi.org/10.3390/medicina60040527

2024-03-23

Abstract:Artificial intelligence (AI) has emerged as a transformative tool in the field of ophthalmology, revolutionizing disease diagnosis and management. This paper provides a comprehensive overview of AI applications in various retinal diseases, highlighting its potential to enhance screening efficiency, facilitate early diagnosis, and improve patient outcomes. Herein, we elucidate the fundamental concepts of AI, including machine learning (ML) and deep learning (DL), and their application in ophthalmology, underscoring the significance of AI-driven solutions in addressing the complexity and variability of retinal diseases. Furthermore, we delve into the specific applications of AI in retinal diseases such as diabetic retinopathy (DR), age-related macular degeneration (AMD), Macular Neovascularization, retinopathy of prematurity (ROP), retinal vein occlusion (RVO), hypertensive retinopathy (HR), Retinitis Pigmentosa, Stargardt disease, best vitelliform macular dystrophy, and sickle cell retinopathy. We focus on the current landscape of AI technologies, including various AI models, their performance metrics, and clinical implications. Furthermore, we aim to address challenges and pitfalls associated with the integration of AI in clinical practice, including the "black box phenomenon", biases in data representation, and limitations in comprehensive patient assessment. In conclusion, this review emphasizes the collaborative role of AI alongside healthcare professionals, advocating for a synergistic approach to healthcare delivery. It highlights the importance of leveraging AI to augment, rather than replace, human expertise, thereby maximizing its potential to revolutionize healthcare delivery, mitigate healthcare disparities, and improve patient outcomes in the evolving landscape of medicine.
Artificial intelligence for retinal diseases

Jennifer I Lim,Aleksandra V Rachitskaya,Joelle A Hallak,Sina Gholami,Minhaj N Alam

DOI: https://doi.org/10.1016/j.apjo.2024.100096

Abstract:Purpose: To discuss the worldwide applications and potential impact of artificial intelligence (AI) for the diagnosis, management and analysis of treatment outcomes of common retinal diseases. Methods: We performed an online literature review, using PubMed Central (PMC), of AI applications to evaluate and manage retinal diseases. Search terms included AI for screening, diagnosis, monitoring, management, and treatment outcomes for age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal surgery, retinal vascular disease, retinopathy of prematurity (ROP) and sickle cell retinopathy (SCR). Additional search terms included AI and color fundus photographs, optical coherence tomography (OCT), and OCT angiography (OCTA). We included original research articles and review articles. Results: Research studies have investigated and shown the utility of AI for screening for diseases such as DR, AMD, ROP, and SCR. Research studies using validated and labeled datasets confirmed AI algorithms could predict disease progression and response to treatment. Studies showed AI facilitated rapid and quantitative interpretation of retinal biomarkers seen on OCT and OCTA imaging. Research articles suggest AI may be useful for planning and performing robotic surgery. Studies suggest AI holds the potential to help lessen the impact of socioeconomic disparities on the outcomes of retinal diseases. Conclusions: AI applications for retinal diseases can assist the clinician, not only by disease screening and monitoring for disease recurrence but also in quantitative analysis of treatment outcomes and prediction of treatment response. The public health impact on the prevention of blindness from DR, AMD, and other retinal vascular diseases remains to be determined.
Comprehensive Review on the Use of Artificial Intelligence in Ophthalmology and Future Research Directions

Nicoleta Anton,Bogdan Doroftei,Silvia Curteanu,Lisa Catãlin,Ovidiu-Dumitru Ilie,Filip Târcoveanu,Camelia Margareta Bogdănici

DOI: https://doi.org/10.3390/diagnostics13010100

IF: 3.6

2022-12-30

Diagnostics

Abstract:Background: Having several applications in medicine, and in ophthalmology in particular, artificial intelligence (AI) tools have been used to detect visual function deficits, thus playing a key role in diagnosing eye diseases and in predicting the evolution of these common and disabling diseases. AI tools, i.e., artificial neural networks (ANNs), are progressively involved in detecting and customized control of ophthalmic diseases. The studies that refer to the efficiency of AI in medicine and especially in ophthalmology were analyzed in this review. Materials and Methods: We conducted a comprehensive review in order to collect all accounts published between 2015 and 2022 that refer to these applications of AI in medicine and especially in ophthalmology. Neural networks have a major role in establishing the demand to initiate preliminary anti-glaucoma therapy to stop the advance of the disease. Results: Different surveys in the literature review show the remarkable benefit of these AI tools in ophthalmology in evaluating the visual field, optic nerve, and retinal nerve fiber layer, thus ensuring a higher precision in detecting advances in glaucoma and retinal shifts in diabetes. We thus identified 1762 applications of artificial intelligence in ophthalmology: review articles and research articles (301 pub med, 144 scopus, 445 web of science, 872 science direct). Of these, we analyzed 70 articles and review papers (diabetic retinopathy (N = 24), glaucoma (N = 24), DMLV (N = 15), other pathologies (N = 7)) after applying the inclusion and exclusion criteria. Conclusion: In medicine, AI tools are used in surgery, radiology, gynecology, oncology, etc., in making a diagnosis, predicting the evolution of a disease, and assessing the prognosis in patients with oncological pathologies. In ophthalmology, AI potentially increases the patient's access to screening/clinical diagnosis and decreases healthcare costs, mainly when there is a high risk of disease or communities face financial shortages. AI/DL (deep learning) algorithms using both OCT and FO images will change image analysis techniques and methodologies. Optimizing these (combined) technologies will accelerate progress in this area.

medicine, general & internal
A Review of the Utility and Limitations of Artificial Intelligence in Retinal Disorders and Pediatric Ophthalmology

Kristie M Labib,Haider Ghumman,Samyak Jain,John S Jarstad

DOI: https://doi.org/10.7759/cureus.71063

2024-10-08

Cureus

Abstract:Artificial intelligence (AI) is reshaping ophthalmology by enhancing diagnostic precision and treatment strategies, particularly in retinal disorders and pediatric ophthalmology. This review examines AI's efficacy in diagnosing conditions such as diabetic retinopathy (DR) and age-related macular degeneration (AMD) using imaging techniques, such as optical coherence tomography (OCT) and fundus photography. AI also shows promise in pediatric care, aiding in the screening of retinopathy of prematurity (ROP) and the management of conditions, including pediatric cataracts and strabismus. However, the integration of AI in ophthalmology presents challenges, including ethical concerns regarding algorithm biases, privacy issues, and limitations in data set quality. Addressing these challenges is crucial to ensure AI's responsible and effective deployment in clinical settings. This review synthesizes current research, underscoring AI's transformative potential in ophthalmology while highlighting critical considerations for its ethical use and technological advancement.
Artificial Intelligence in Ophthalmology – Status Quo and Future Perspectives

Philomena A. Wawer Matos,Robert P. Reimer,Alexander C. Rokohl,Liliana Caldeira,Ludwig M. Heindl,Nils Große Hokamp

DOI: https://doi.org/10.1080/08820538.2022.2139625

2022-11-12

Seminars in Ophthalmology

Abstract:Artificial intelligence (AI) is an emerging technology in healthcare and holds the potential to disrupt many arms in medical care. In particular, disciplines using medical imaging modalities, including e.g. radiology but ophthalmology as well, are already confronted with a wide variety of AI implications. In ophthalmologic research, AI has demonstrated promising results limited to specific diseases and imaging tools, respectively. Yet, implementation of AI in clinical routine is not widely spread due to availability, heterogeneity in imaging techniques and AI methods. In order to describe the status quo, this narrational review provides a brief introduction to AI ("what the ophthalmologist needs to know"), followed by an overview of different AI-based applications in ophthalmology and a discussion on future challenges. Abbreviations : Age-related macular degeneration, AMD; Artificial intelligence, AI; Anterior segment OCT, AS-OCT; Coronary artery calcium score, CACS; Convolutional neural network, CNN; Deep convolutional neural network, DCNN; Diabetic retinopathy, DR; Machine learning, ML; Optical coherence tomography, OCT; Retinopathy of prematurity, ROP; Support vector machine, SVM; Thyroid-associated ophthalmopathy, TAO

ophthalmology
Artificial intelligence in ophthalmology: the present and the future

V. V. Neroev,O. V. Zaytseva,S. Yu. Petrov,A. A. Bragin

DOI: https://doi.org/10.21516/2072-0076-2024-17-2-135-141

2024-07-02

Russian Ophthalmological Journal

Abstract:The medical industry is undergoing an active digital transformation, including the creation of electronic databases, cloud security systems, mobile health monitoring devices, and telemedicine tools. Artificial intelligence (AI), one of the most important technological achievements of the last decade, is gradually gaining momentum in various areas of practical medicine. The cutting edge of AI, neural networks, offers promising approaches to the improvement of clinical examination quality. The review presents data of studies focusing on the use of AI tools in the diagnosis of the most common ophthalmic diseases: diabetic retinopathy, macular degeneration, retinopathy of prematurity, glaucoma, cataracts, and ophthalmic oncology. We discuss both the advantages of neural networks in the diagnosis and monitoring of eye diseases, and outline the difficulties of their implementation, including ethical and legal conflicts.
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus

Yu-Bai Chou,Aditya U Kale,Paolo Lanzetta,Tariq Aslam,Jane Barratt,Carla Danese,Bora Eldem,Nicole Eter,Richard Gale,Jean-François Korobelnik,Igor Kozak,Xiaorong Li,Xiaoxin Li,Anat Loewenstein,Paisan Ruamviboonsuk,Taiji Sakamoto,Daniel S W Ting,Peter van Wijngaarden,Sebastian M Waldstein,David Wong,Lihteh Wu,Miguel A Zapata,Javier Zarranz-Ventura,Aditya U. Kale,Daniel S.W. Ting,Sebastian M. Waldstein,Miguel A. Zapata

DOI: https://doi.org/10.1097/icu.0000000000000979

2023-06-16

Current Opinion in Ophthalmology

Abstract:PURPOSE OF REVIEW: The application of artificial intelligence (AI) technologies in screening and diagnosing retinal diseases may play an important role in telemedicine and has potential to shape modern healthcare ecosystems, including within ophthalmology.RECENT FINDINGS: In this article, we examine the latest publications relevant to AI in retinal disease and discuss the currently available algorithms. We summarize four key requirements underlining the successful application of AI algorithms in real-world practice: processing massive data; practicability of an AI model in ophthalmology; policy compliance and the regulatory environment; and balancing profit and cost when developing and maintaining AI models.SUMMARY: The Vision Academy recognizes the advantages and disadvantages of AI-based technologies and gives insightful recommendations for future directions.

ophthalmology
Artificial intelligence in retinal imaging: current status and future prospects

Katharina A Heger,Sebastian M Waldstein

DOI: https://doi.org/10.1080/17434440.2023.2294364

Abstract:Introduction: The steadily growing and aging world population, in conjunction with continuously increasing prevalences of vision-threatening retinal diseases, is placing an increasing burden on the global healthcare system. The main challenges within retinology involve identifying the comparatively few patients requiring therapy within the large mass, the assurance of comprehensive screening for retinal disease and individualized therapy planning. In order to sustain high-quality ophthalmic care in the future, the incorporation of artificial intelligence (AI) technologies into our clinical practice represents a potential solution. Areas covered: This review sheds light onto already realized and promising future applications of AI techniques in retinal imaging. The main attention is directed at the application in diabetic retinopathy and age-related macular degeneration. The principles of use in disease screening, grading, therapeutic planning and prediction of future developments are explained based on the currently available literature. Expert opinion: The recent accomplishments of AI in retinal imaging indicate that its implementation into our daily practice is likely to fundamentally change the ophthalmic healthcare system and bring us one step closer to the goal of individualized treatment. However, it must be emphasized that the aim is to optimally support clinicians by gradually incorporating AI approaches, rather than replacing ophthalmologists.
Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives

Kai Jin,Juan Ye

DOI: https://doi.org/10.1016/j.aopr.2022.100078

2022-11-01

Advances in Ophthalmology Practice and Research

Abstract:BackgroundThe ophthalmology field was among the first to adopt artificial intelligence (AI) in medicine. The availability of digitized ocular images and substantial data have made deep learning (DL) a popular topic.Main textAt the moment, AI in ophthalmology is mostly used to improve disease diagnosis and assist decision-making aiming at ophthalmic diseases like diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), cataract and other anterior segment diseases. However, most of the AI systems developed to date are still in the experimental stages, with only a few having achieved clinical applications. There are a number of reasons for this phenomenon, including security, privacy, poor pervasiveness, trust and explainability concerns.ConclusionsThis review summarizes AI applications in ophthalmology, highlighting significant clinical considerations for adopting AI techniques and discussing the potential challenges and future directions.
Artificial intelligence in retinal disease: clinical application, challenges, and future directions

Malena Daich Varela,Sagnik Sen,Thales Antonio Cabral De Guimaraes,Nathaniel Kabiri,Nikolas Pontikos,Konstantinos Balaskas,Michel Michaelides

DOI: https://doi.org/10.1007/s00417-023-06052-x

Abstract:Retinal diseases are a leading cause of blindness in developed countries, accounting for the largest share of visually impaired children, working-age adults (inherited retinal disease), and elderly individuals (age-related macular degeneration). These conditions need specialised clinicians to interpret multimodal retinal imaging, with diagnosis and intervention potentially delayed. With an increasing and ageing population, this is becoming a global health priority. One solution is the development of artificial intelligence (AI) software to facilitate rapid data processing. Herein, we review research offering decision support for the diagnosis, classification, monitoring, and treatment of retinal disease using AI. We have prioritised diabetic retinopathy, age-related macular degeneration, inherited retinal disease, and retinopathy of prematurity. There is cautious optimism that these algorithms will be integrated into routine clinical practice to facilitate access to vision-saving treatments, improve efficiency of healthcare systems, and assist clinicians in processing the ever-increasing volume of multimodal data, thereby also liberating time for doctor-patient interaction and co-development of personalised management plans.
Artificial Intelligence and Advanced Technology in Glaucoma: A Review

Emanuele Tonti,Sofia Tonti,Flavia Mancini,Chiara Bonini,Leopoldo Spadea,Fabiana D'Esposito,Caterina Gagliano,Mutali Musa,Marco Zeppieri

DOI: https://doi.org/10.3390/jpm14101062

2024-10-16

Abstract:Background: Glaucoma is a leading cause of irreversible blindness worldwide, necessitating precise management strategies tailored to individual patient characteristics. Artificial intelligence (AI) holds promise in revolutionizing the approach to glaucoma care by providing personalized interventions. Aim: This review explores the current landscape of AI applications in the personalized management of glaucoma patients, highlighting advancements, challenges, and future directions. Methods: A systematic search of electronic databases, including PubMed, Scopus, and Web of Science, was conducted to identify relevant studies published up to 2024. Studies exploring the use of AI techniques in personalized management strategies for glaucoma patients were included. Results: The review identified diverse AI applications in glaucoma management, ranging from early detection and diagnosis to treatment optimization and prognosis prediction. Machine learning algorithms, particularly deep learning models, demonstrated high accuracy in diagnosing glaucoma from various imaging modalities such as optical coherence tomography (OCT) and visual field tests. AI-driven risk stratification tools facilitated personalized treatment decisions by integrating patient-specific data with predictive analytics, enhancing therapeutic outcomes while minimizing adverse effects. Moreover, AI-based teleophthalmology platforms enabled remote monitoring and timely intervention, improving patient access to specialized care. Conclusions: Integrating AI technologies in the personalized management of glaucoma patients holds immense potential for optimizing clinical decision-making, enhancing treatment efficacy, and mitigating disease progression. However, challenges such as data heterogeneity, model interpretability, and regulatory concerns warrant further investigation. Future research should focus on refining AI algorithms, validating their clinical utility through large-scale prospective studies, and ensuring seamless integration into routine clinical practice to realize the full benefits of personalized glaucoma care.
Artificial intelligence in glaucoma: opportunities, challenges, and future directions

Xiaoqin Huang,Md Rafiqul Islam,Shanjita Akter,Fuad Ahmed,Ehsan Kazami,Hashem Abu Serhan,Alaa Abd-Alrazaq,Siamak Yousefi

DOI: https://doi.org/10.1186/s12938-023-01187-8

2023-12-16

Abstract:Artificial intelligence (AI) has shown excellent diagnostic performance in detecting various complex problems related to many areas of healthcare including ophthalmology. AI diagnostic systems developed from fundus images have become state-of-the-art tools in diagnosing retinal conditions and glaucoma as well as other ocular diseases. However, designing and implementing AI models using large imaging data is challenging. In this study, we review different machine learning (ML) and deep learning (DL) techniques applied to multiple modalities of retinal data, such as fundus images and visual fields for glaucoma detection, progression assessment, staging and so on. We summarize findings and provide several taxonomies to help the reader understand the evolution of conventional and emerging AI models in glaucoma. We discuss opportunities and challenges facing AI application in glaucoma and highlight some key themes from the existing literature that may help to explore future studies. Our goal in this systematic review is to help readers and researchers to understand critical aspects of AI related to glaucoma as well as determine the necessary steps and requirements for the successful development of AI models in glaucoma.
Role of Artificial Intelligence in Retinal Diseases

Julia Mai,Ursula Schmidt-Erfurth

DOI: https://doi.org/10.1055/a-2378-6138

Abstract:Artificial intelligence (AI) has already found its way into ophthalmology, with the first approved algorithms that can be used in clinical routine. Retinal diseases in particular are proving to be an important area of application for AI, as they are the main cause of blindness and the number of patients suffering from retinal diseases is constantly increasing. At the same time, regular imaging using high-resolution modalities in a standardised and reproducible manner generates immense amounts of data that can hardly be processed by human experts. In addition, ophthalmology is constantly experiencing new developments and breakthroughs that require a re-evaluation of patient management in routine clinical practice. AI is able to analyse these volumes of data efficiently and objectively and also provide new insights into disease progression and therapeutic mechanisms by identifying relevant biomarkers. AI can make a significant contribution to screening, classification and prognosis of various retinal diseases and can ultimately be a clinical decision support system, that significantly reduces the burden on both everyday clinical practice and the healthcare system, by making more efficient use of costly and time-consuming resources.
Artificial intelligence in the anterior segment of eye diseases

Yao-Hong Liu,Lin-Yu Li,Si-Jia Liu,Li-Xiong Gao,Yong Tang,Zhao-Hui Li,Zi Ye

DOI: https://doi.org/10.18240/ijo.2024.09.23

2024-09-18

Abstract:Ophthalmology is a subject that highly depends on imaging examination. Artificial intelligence (AI) technology has great potential in medical imaging analysis, including image diagnosis, classification, grading, guiding treatment and evaluating prognosis. The combination of the two can realize mass screening of grass-roots eye health, making it possible to seek medical treatment in the mode of "first treatment at the grass-roots level, two-way referral, emergency and slow treatment, and linkage between the upper and lower levels". On the basis of summarizing the AI technology carried out by scholars and their teams all over the world in the field of ophthalmology, quite a lot of studies have confirmed that machine learning can assist in diagnosis, grading, providing optimal treatment plans and evaluating prognosis in corneal and conjunctival diseases, ametropia, lens diseases, glaucoma, iris diseases, etc. This paper systematically shows the application and progress of AI technology in common anterior segment ocular diseases, the current limitations, and prospects for the future.
Artificial intelligence in individualized retinal disease management

Zi-Ran Zhang,Jia-Jun Li,Ke-Ran Li

DOI: https://doi.org/10.18240/ijo.2024.08.19

2024-08-18

Abstract:Owing to the rapid development of modern computer technologies, artificial intelligence (AI) has emerged as an essential instrument for intelligent analysis across a range of fields. AI has been proven to be highly effective in ophthalmology, where it is frequently used for identifying, diagnosing, and typing retinal diseases. An increasing number of researchers have begun to comprehensively map patients' retinal diseases using AI, which has made individualized clinical prediction and treatment possible. These include prognostic improvement, risk prediction, progression assessment, and interventional therapies for retinal diseases. Researchers have used a range of input data methods to increase the accuracy and dependability of the results, including the use of tabular, textual, or image-based input data. They also combined the analyses of multiple types of input data. To give ophthalmologists access to precise, individualized, and high-quality treatment strategies that will further optimize treatment outcomes, this review summarizes the latest findings in AI research related to the prediction and guidance of clinical diagnosis and treatment of retinal diseases.
Do pediatric healthcare providers know how to use metered dose inhaler plus spacer devices?

Kelechi N. Iheagwara,I. Sharif,P. Ozuah

DOI: https://doi.org/10.1016/J.PCRJ.2005.01.001

2005-06-01

Primary Care Respiratory Journal

Abstract:
Understanding required to consider AI applications to the field of ophthalmology

Hitoshi Tabuchi

DOI: https://doi.org/10.4103/tjo.tjo_8_22

2022-01-01

Taiwan Journal of Ophthalmology

Abstract:Applications of artificial intelligence technology, especially deep learning, in ophthalmology research have started with the diagnosis of diabetic retinopathy and have now expanded to all areas of ophthalmology, mainly in the identification of fundus diseases such as glaucoma and age-related macular degeneration. In addition to fundus photography, optical coherence tomography is often used as an imaging device. In addition to simple binary classification, region identification (segmentation model) is used as an identification method for interpretability. Furthermore, there have been AI applications in the area of regression estimation, which is different from diagnostic identification. While expectations for deep learning AI are rising, regulatory agencies have begun issuing guidance on the medical applications of AI. The reason behind this trend is that there are a number of existing issues regarding the application of AI that need to be considered, including, but not limited to, the handling of personal information by large technology companies, the black-box issue, the flaming issue, the theory of responsibility, and issues related to improving the performance of commercially available AI. Furthermore, researchers have reported that there are a plethora of issues that simply cannot be solved by the high performance of artificial intelligence models, such as educating users and securing the communication environment, which are just a few of the necessary steps toward the actual implementation process of an AI society. Multifaceted perspectives and efforts are needed to create better ophthalmology care through AI.

Spinal injuries and BMX bicycles.

An overview of artificial intelligence in diabetic retinopathy and other ocular diseases

Artificial intelligence and machine learning in ophthalmology: A review

Artificial Intelligence in Ophthalmic Surgery: Current Applications and Expectations

Artificial Intelligence (AI) for Early Diagnosis of Retinal Diseases

Artificial intelligence for retinal diseases

Comprehensive Review on the Use of Artificial Intelligence in Ophthalmology and Future Research Directions

A Review of the Utility and Limitations of Artificial Intelligence in Retinal Disorders and Pediatric Ophthalmology

Artificial Intelligence in Ophthalmology – Status Quo and Future Perspectives

Artificial intelligence in ophthalmology: the present and the future

Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus

Artificial intelligence in retinal imaging: current status and future prospects

Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives

Artificial intelligence in retinal disease: clinical application, challenges, and future directions

Artificial Intelligence and Advanced Technology in Glaucoma: A Review

Artificial intelligence in glaucoma: opportunities, challenges, and future directions

Role of Artificial Intelligence in Retinal Diseases

Artificial intelligence in the anterior segment of eye diseases

Artificial intelligence in individualized retinal disease management

Do pediatric healthcare providers know how to use metered dose inhaler plus spacer devices?

Understanding required to consider AI applications to the field of ophthalmology